Table 2.
Variable | Univariate | Multivariate* | ||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
N-total | N-events | HR (95%CI) | P-value | N-total | N-events | HR (95%CI) | P-value | |
HAS2 | 93 | 14 | 1.29 (0.73–2.27) | 0.381 | 87 | 13 | 1.66 (0.90–3.03) | 0.102 |
HA | 94 | 15 | 1.66 (0.97–2.83) | 0.065 | 88 | 14 | 1.74 (1.01–2.99) | 0.047 |
HYAL1 | 93 | 13 | 1.54 (0.88–2.68) | 0.131 | 87 | 12 | 1.63 (0.86–3.12) | 0.136 |
CD44 | 92 | 13 | 0.87 (0.50–1.54) | 0.642 | 86 | 12 | 0.75 (0.42–1.35) | 0.339 |
CD44v6 | 91 | 13 | 1.24 (0.77–2.00) | 0.376 | 85 | 12 | 1.34 (0.79–2.26) | 0.282 |
HMMR | 89 | 13 | 2.00 (1.08–3.71) | 0.028 | 83 | 12 | 2.03 (1.04–3.99) | 0.040 |
Adjusted for age at prostatectomy, preoperative PSA, primary Gleason pattern, and Non-Localized Tumor Indicator.